Chang, A. B. Et Al. 2022. Task Force report: European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials. European Respiratory Journal , vol.60, no.5 .

Chang, A. B., Zacharasiewicz, A., Goyal, V., Boyd, J., Alexopoulou, E., Aliberti, S., ... Bell, L.(2022). Task Force report: European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials. European Respiratory Journal , vol.60, no.5.

Chang, Anne Et Al. "Task Force report: European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials," European Respiratory Journal , vol.60, no.5, 2022

Chang, Anne B. Et Al. "Task Force report: European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials." European Respiratory Journal , vol.60, no.5, 2022

Chang, A. B. Et Al. (2022) . "Task Force report: European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials." European Respiratory Journal , vol.60, no.5.

@article{article, author={Anne B. Chang Et Al. }, title={Task Force report: European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials}, journal={European Respiratory Journal}, year=2022}